News
Drugmakers that dominate the world's insulin market must scale up access efforts globally
06 October 2022
Amsterdam Session on Diabetes Care - Meeting Report
On 15 June 2023, the Access to Medicine Foundation convened an "Amsterdam Session" to discuss solutions for improving access to essential treatment and health commodities for insulin-dependent people living with diabetes in low- and middle-income countries. Insights and conclusions from the day's roundtable discussions have been captured in a meeting report, which is now available for download.
Date
25 July 2023
In addition to representatives of some of the leading manufacturers of insulins and glucose self-monitoring devices for diabetes, participants included experts from global health organisations, procurement agencies and government bodies.
The roundtable was held under the Chatham House Rule, in order to encourage a free and open exchange of ideas. It was moderated by the Access to Medicine Foundation's CEO, Jayasree K. Iyer, and was the latest event in the Foundation's Diabetes Care Programme.
Takeaways from the event
Points raised during the discussion, as well as examples of challenges and solutions, have been summarised in the meeting report under the following five headers:
Engage and involve people living with diabetes;
Develop business models and products specifically for LMICs;
Increase the involvement of and partnership with device manufacturers;
Shape a collaborative supply chain to the last mile;
Scale up healthcare capacity locally to support Universal Healthcare (UHC).Â
These five points each highlight some of the practical steps that companies can take to expand access to diabetes care in LMICs. Further details of the discussion are shared in the PDF of the meeting report.
